sulforaphane has been researched along with triptolide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fu, X; Guan, C; Huang, M; Huang, Z; Jin, J; Li, J; Shen, F; Sun, X; Wang, W | 1 |
Dhanasekaran, DN; Han, Y; Jo, H; Kim, H; Kim, S; Kim, SJ; Lee, J; Song, YS; Wang, W; Yang, KM | 1 |
1 review(s) available for sulforaphane and triptolide
Article | Year |
---|---|
Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy.
Topics: Animals; Antigens, CD; Antineoplastic Agents; B7 Antigens; B7-H1 Antigen; Camptothecin; CTLA-4 Antigen; Diterpenes; Epoxy Compounds; Flavonoids; Hepatitis A Virus Cellular Receptor 2; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Isothiocyanates; Lymphocyte Activation Gene 3 Protein; Mice; Neoplasms; Phenanthrenes; Phytochemicals; Plant Extracts; Programmed Cell Death 1 Receptor; Receptors, Immunologic; Saponins; Sulfoxides; Terpenes; Tumor Microenvironment | 2021 |
1 other study(ies) available for sulforaphane and triptolide
Article | Year |
---|---|
Activation of Nrf2 protects against triptolide-induced hepatotoxicity.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Diterpenes; Epoxy Compounds; Hep G2 Cells; Humans; Isothiocyanates; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Oxidative Stress; Phenanthrenes; Sulfoxides | 2014 |